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Abstract 
Microbeam radiation therapy (MRT) is a promising radiotherapy modality that uses arrays of spatially 
fractionated micrometre-sized beams of synchrotron radiation to irradiate tumours. Routine dosimetry 
quality assurance (QA) prior to treatment is necessary to identify any changes in beam condition from the 
treatment plan, and is undertaken using solid homogeneous phantoms. Solid phantoms are designed for, 
and routinely used in, megavoltage X-ray beam radiation therapy. These solid phantoms are not 
necessarily designed to be water-equivalent at low X-ray energies, and therefore may not be suitable for 
MRT QA. This work quantitatively determines the most appropriate solid phantom to use in dosimetric 
MRT QA. Simulated dose profiles of various phantom materials were compared with those calculated in 
water under the same conditions. The phantoms under consideration were RMI457 Solid Water 
(Gammex-RMI, Middleton, WI, USA), Plastic Water (CIRS, Norfolk, VA, USA), Plastic Water DT (CIRS, 
Norfolk, VA, USA), PAGAT (CIRS, Norfolk, VA, USA), RW3 Solid Phantom (PTW Freiburg, Freiburg, 
Germany), PMMA, Virtual Water (Med-Cal, Verona, WI, USA) and Perspex. RMI457 Solid Water and Virtual 
Water were found to be the best approximations for water in MRT dosimetry (within ±3% deviation in peak 
and 6% in valley). RW3 and Plastic Water DT approximate the relative dose distribution in water (within 
±3% deviation in the peak and 5% in the valley). PAGAT, PMMA, Perspex and Plastic Water are not 
recommended to be used as phantoms for MRT QA, due to dosimetric discrepancies greater than 5%. 
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Comparison of phantom materials for use in quality
assurance of microbeam radiation therapy
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Microbeam radiation therapy (MRT) is a promising radiotherapy modality that
uses arrays of spatially fractionated micrometre-sized beams of synchrotron
radiation to irradiate tumours. Routine dosimetry quality assurance (QA) prior
to treatment is necessary to identify any changes in beam condition from the
treatment plan, and is undertaken using solid homogeneous phantoms. Solid
phantoms are designed for, and routinely used in, megavoltage X-ray beam
radiation therapy. These solid phantoms are not necessarily designed to be
water-equivalent at low X-ray energies, and therefore may not be suitable for
MRT QA. This work quantitatively determines the most appropriate solid
phantom to use in dosimetric MRT QA. Simulated dose profiles of various
phantom materials were compared with those calculated in water under the
same conditions. The phantoms under consideration were RMI457 Solid Water
(Gammex-RMI, Middleton, WI, USA), Plastic Water (CIRS, Norfolk, VA,
USA), Plastic Water DT (CIRS, Norfolk, VA, USA), PAGAT (CIRS, Norfolk,
VA, USA), RW3 Solid Phantom (PTW Freiburg, Freiburg, Germany), PMMA,
Virtual Water (Med-Cal, Verona, WI, USA) and Perspex. RMI457 Solid Water
and Virtual Water were found to be the best approximations for water in MRT
dosimetry (within 3% deviation in peak and 6% in valley). RW3 and Plastic
Water DT approximate the relative dose distribution in water (within 3%
deviation in the peak and 5% in the valley). PAGAT, PMMA, Perspex and
Plastic Water are not recommended to be used as phantoms for MRT QA, due
to dosimetric discrepancies greater than 5%.
1. Introduction
Microbeam radiation therapy (MRT) is a preclinical radio-
therapy modality consisting of many micrometre-sized
spatially fractionated radiation fields, obtained by collimating
a beam of synchrotron radiation with a multi-slit collimator
(Zeman et al., 1959; Schültke et al., 2008; Bräuer-Krisch et al.,
2010). A typical radiation field of MRT consists of an array of
microbeams, each with a width of 50 mm and a centre-to-
centre distance of 400 mm.
MRT differs from external beam radiation therapy (EBRT)
due to the properties of synchrotron radiation, such as the
small angular divergence of the photon beam, the broad
spectrum of energies available and the pulsed high-intensity
radiation that is produced (Bräuer-Krisch et al., 2010). The low
divergence of the beam ensures that the field does not spread
out as it passes through the patient, thus maintaining the
spatial fractionation at depth; the high-intensity radiation
allows treatment time to be reduced, thus reducing smearing
of the microbeam paths in the tissues due to breathing or
cardiosynchronous motion.
ISSN 1600-5775
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The most significant advantage of MRT over EBRT is the
different radiobiological response of cancerous and healthy
tissues to the micrometre-sized MRT field. As the size of the
radiation field decreases to the order of micrometres the dose
tolerated by normal tissue increases dramatically, whilst
maintaining tumour control (Zeman et al., 1959; Bräuer-
Krisch et al., 2010). This phenomenon, called the dose-volume
effect, makes MRT a promising treatment for radioresistant
tumours such as osteosarcomas, or tumours located within or
near sensitive structures (e.g. glioblastomas in paediatric
patients).
The dose tolerance of normal tissue remains the limiting
factor in the delivery of dose using MRT. The peak-to-valley
dose ratio (PVDR) (Siegbahn et al., 2006) is an important
dosimetric quantity for MRT that determines the effectiveness
of the treatment. A high PVDR means that greater peak doses
can be delivered for the same valley dose which, along with
the out-of-field dose caused by scattering, must be well below
normal tissue tolerance for an acceptable patient clinical
outcome (Rothkamm et al., 2012).
MRT is still in the pre-clinical stage, and more research is
needed before progressing to clinical trials. The ID17 bio-
medical beamline of the European Synchrotron Radiation
Facility (ESRF, Grenoble, France) has developed the world’s
first MRT facility capable of routine irradiation of tumour-
bearing rodents. A treatment planning system has been
developed for preclinical trials (Bartzsch, 2011; Debus, 2012),
irradiation of implanted tumors in rodents is ongoing
(Fernandez-Palomo et al., 2015), and pet animal patient trials
on pets such as cats and dogs have commenced recently
(Bravin et al., 2015).
Effective quality assurance (QA) for MRT is necessary to
mitigate the risk of delivering an incorrect dose to the patient
(Ortiz et al., 2009). Because of the complex system of radiation
field delivery, it is crucial to establish a QA procedure to
predict the dose delivered to the patient very accurately.
The IAEA TRS-398 code of practice recommends that
dosimetric QA be based on a standard of absorbed dose to
water (Andreo et al., 2000). The recommendation is to
perform relative dose measurements in a water tank phantom
as water is considered the best widely available alternative to
soft tissue for most energies (Svensson et al., 1994). This is due
to the fact that the human body is largely water, thus
absorption and scatter properties are very similar.
Unfortunately, water tank phantoms can be inconvenient to
set up correctly due to time required for filling, positioning
and draining, and so are generally used for quarterly or annual
QA tests. Additionally, few commercial waterproof dosi-
meters are available for high-spatial-resolution dosimetry at
the micrometre scale as applicable to synchrotron radiation.
Radiochromic film is capable of resolving dose at the neces-
sary spatial resolution, but is hampered by a long development
time (Crosbie et al., 2008). The PTW microDiamond detector
is capable of real-time dosimetry of synchrotron microbeams,
but set-up requires a lengthy and difficult alignment process to
avoid geometric effects degrading spatial resolution (Living-
ston et al., 2016). Unique silicon single strip detectors, which
are specially packed in a kapton pigtail used for MRT real-
time dosimetry (Rosenfeld et al., 2005; Petasecca et al., 2012;
Lerch et al., 2011, 2017), have been used in water but have not
been specifically designed for that.
The small radiation field (with field sizes of 10 mm 10 mm
as opposed to 10 cm  10 cm for EBRT) and the delivery of
micrometre-sized photon beams can have an impact on the
scattering properties of the radiation field in the phantom.
Siegbahn et al. (2006) state that photon scattering is mostly
responsible for dose in the middle of the valley and electron
scattering contributes mostly to dose closer to the peak (De
Felici et al., 2005). Others have noted preferential out-of-field
scatter due to the polarization of the synchrotron radiation
(Bartzsch et al., 2014) which influences the valley dose and
out-of-field dose. The dose in these areas is a limiting factor
for treatment as it must be kept below normal tissue tolerance
and thus must be accurately known for effective QA and
treatment.
An alternative to water tank phantoms is the use of water-
equivalent solid phantoms, which are preferred for routine
QA to verify the correct beam properties prior to treatment
due to ease of use and speed of measurement. However, the
different composition of the solid phantoms means that the
absorption and scattering properties may not match those of
water. Hugtenburg et al. (2010) suggest that the dosimetric
accuracy should be within 5% for a successful clinical outcome
whereas the IAEA (Andreo et al., 2004) recommends an
accuracy of 3% and ICRU Report 44 recommends that
correction factors are required if uncertainties are greater
than 1% (ICRU, 1989).
Owing to the inherent difficulty of dosimetry of such small
radiation fields, uncertainties of up to or even greater than
10% may be considered ‘acceptable’ during this preclinical
stage depending on the decision of the individual. A reference
acceptable limit of relative dosimetric differences between
solid and water phantoms for MRT QA is yet to be agreed
upon. This is an important issue, which is one of the goals
of the Dosimetry and Treatment Planning Working Group of
the SYRA3 COST action (https://www.syra3.eu/). Recently,
Fournier et al. (2016) published a paper outlining a standard
method for dosimetry of MRT using a PinPoint ion chamber,
and provides an uncertainty of ion chamber measurements
of 4.4%.
Hill et al. (2010, 2014) have shown that phantom materials
may not be water-equivalent (and thus tissue-equivalent) in
the low-energy X-ray region. This was tested for a number of
phantom materials at energies between 50 kVp (approximate
mean energy 17 keV, approximate maximum energy 50 keV)
and 280 kVp (approximate mean energy 93 keV, approximate
maximum energy 280 keV). The radiological water equiva-
lence of commonly used solid phantoms has never been
studied for a synchrotron beam.
Since solid phantoms are the most widely used for daily QA
in clinical practice, it is vital to study which phantom materials
are suitable for absolute and relative dosimetry for MRT QA.
This project investigates the suitability of different solid
phantoms commercially available for MRT by means of
research papers
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Monte Carlo simulations. The phantoms under study were:
RMI457 Solid Water (Gammex-RMI, Middleton, WI, USA),
Plastic Water (CIRS, Norfolk, VA, USA), Plastic Water DT
(CIRS, Norfolk, VA, USA), PAGAT (Computerized Imaging
Reference Systems), RW3 Solid Phantom (PTW Freiburg,
Freiburg, Germany), PMMA from Virtual Water (Med-Cal,
Verona, WI, USA) and Perspex.
Previous studies have determined the radiological water
equivalence of phantoms in low-energy X-ray beams in
conventional kilovoltage X-ray radiotherapy (Hill et al., 2010,
2014). Our study focuses on studying the applicability of these
phantom materials in typical photon spectra used in MRT.
2. Method
2.1. Comparison of phantom mass energy-absorption
coefficients
Radiological water-equivalence of homogeneous phantoms
is determined by how well the attenuation and scattering
properties of the material agree with those of water. Given the
dependence of the attenuation coefficient on the incident
photon energy, which has direct correlation to the theoretical
calculation of water equivalence, it is necessary to know the
energy spectrum in detail. Thus, provided good characteriza-
tion of the energy spectrum of the radiation field that will
interact with the material, a theoretical estimate of radi-
ological water-equivalence can be obtained. The energy
spectrum of the incident radiation field used in this paper
is derived from Cornelius et al. (2014) which models, using
Geant4, the geometry of the ESRF ID17 biomedical beamline
and is already well matched to experimental results (see Fig. 1).
Photon energies range approximately between 20 keV and
300 keV, with an average energy of 100 keV as calculated from
the spectrum of X-rays at the entrance to the phantom.
The mass energy-absorption coefficients en= of the
alternative phantom materials were calculated to provide a
first measure of radiological water equivalence, as done by
Brown et al. (2008). Then the work was refined by studying
the radiological water-equivalence of the solid phantoms by
means of Monte Carlo simulations as they provide an accurate
description of the beam geometry, attenuation and scattering
of the polarized photon beam, detailed transport of secondary
electrons, and calculation of the dose at the micrometre scale,
which is required by MRT-related studies.
The mass energy-absorption coefficients of the phantom
materials under study were approximated using a fraction-by-
weight formula from the mass energy-absorption coefficients
of the component elements of the investigated material. This
approximation is known to underestimate the true mass
energy-absorption coefficient of the composite material by up
to 5% for mixtures of high- and low-Z and high photon
energies (Attix, 1984) but will suffice for this preliminary
study. Elemental mass energy-absorption coefficients were
taken from Hubbell & Seltzer (1993) and mass energy-















where n is the number of elements in the material, i is the
index of the element to be summed, and wi is the fraction by
weight of the ith element in the compound.
The percentage difference of mass energy-absorption
coefficient ð en=Þ for a given solid phantom (p) to water
(w) was calculated as follows,
 en=ð Þ ¼
en=ð Þp  en=ð Þw
en=ð Þw
 100: ð2Þ
2.2. The Geant4 simulation application
The study was performed with the Geant4-based application
modelling the ESRF ID17 biomedical beamline (Grenoble,
France), described by Cornelius et al. (2014). Geant4 is a
Monte Carlo (MC) simulation toolkit modelling the inter-
actions of particles with matter (Agostinelli et al., 2003;
Allison et al., 2006, 2016). The Geant4 version used in this
project was 4.9.6, patch 02.
The SHADOW code (Sanchez del Rio et al., 2011) was
adopted to model the synchrotron X-ray production in the
ID17 wiggler. The photons were then transported through the
ID17 beamline, including the ionization chambers, filters,
multi-slit collimator (MSC) and a 20 cm  30 cm  30 cm
homogeneous solid phantom of the material under examina-
tion, as described by Cornelius et al. (2014). A simplified
diagram of part of the geometry and the coordinate system
used in the simulation experimental set-up is shown
in Fig. 2.
The different phantom materials under study were
modelled in the Geant4 simulation. The material character-
istics (density and chemical composition) of all materials
except Perspex were obtained from Hill et al. (2008).
However, in the cases of Plastic Water, Plastic Water DT,
research papers
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Figure 1
Energy spectrum of the synchrotron radiation produced by the ESRF
biomedical beamline ID17 wiggler incident on the phantom, calculated by
Cornelius et al. (2014).
Virtual Water and PAGAT the total fractional weights were
not equal to unity and thus the element with the largest
fractional weight was increased slightly (0.0005) to achieve
unity. The chosen element in PAGAT was oxygen and in all
other cases the chosen element was carbon.
The material characteristics of Perspex were taken from
NIST (Berger et al., 1998). Table 1 reports the chemical
composition and the density of the phantom materials under
study. It should be noted that exact material characteristics of
solid phantoms in reality vary depending on many factors
during the manufacturing process.
Two beam configurations were simulated in order to
investigate the effect of the phantom material on dose distri-
bution. The first configuration under study (henceforth called
broad-beam configuration) produces a broad field by scanning
the phantom through a 10 mm (y direction)  0.5 mm
(z direction) beam without the MSC in place. Broad-beam
is used to examine dose distribution in a non-collimated
synchrotron radiation field in order to establish trends of the
material responses and provide a comparison point for
previous small-field low-energy EBRT results.
The second configuration under study (henceforth called
microbeam configuration) was selected to determine the effect
of the phantom material on the microbeam dose distribution.
To achieve this goal, the MSC was placed in the synchrotron
beam to produce 125 microbeams, each with a width of 50 mm,
500 mm height and pitch of 400 mm.
The low-energy Livermore polarized physics package
(Chauvie et al., 2004) was adopted to model the electro-
magnetic interactions of particles in the simulation down to
a 250 eV low-energy limit. The photon cross sections were
validated over the energy range between 1 keV and 100 GeV
against the NIST reference data (Amako et al., 2005). The
simulation has been validated with respect to experimental
measurements using EBT2 GafChromic film (International
Specialty Products, Wayne, NJ, USA) and a PinPoint 31014
(PTW Freiburg, Freiburg, Germany) ionization chamber
(Cornelius et al., 2014).
The energy deposition in the phantom was calculated at the
centre of 2 mm  0.2 mm  0.2 mm scoring voxels for the
broad-beam setup and at the centre of 1 mm  0.01 mm 
0.1 mm scoring voxels in the microbeam configuration. The
total energy deposited in keV in each voxel was converted to
dose in Gy deposited for analysis post-simulation.
A cut (threshold of production of secondary particles
expressed in range) of 0.01 mm, corresponding to the length of
the smallest voxel dimension, was applied within the phantom
in order to reduce simulation times. Additionally, particles
were stored in a phase space store placed between the MSC
and the phantom in order to reuse the incident radiation field
when studying phantoms of different materials without
needing to generate primary photons and transport through
the beamline for each different simulation set-up.
2.3. Analysis of the results
The absolute dose deposited in the phantom per incident
photon was calculated in the voxels of the phantom in units of
Gray (Gy). The dose within each voxel of the solid phantom
(Dp) was compared with the dose in identically sized and
positioned voxels in a water phantom of identical dimensions
research papers
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Table 1
Material composition of phantom materials under investigation.















H 0.1119 0.0809 0.0925 0.0759 0.0805 0.0770 0.074 0.1059 0.0805
B – – – – – – 0.0226 – –
C – 0.6722 0.6287 0.9041 0.5998 0.6873 0.4674 0.0681 0.5999
N – 0.024 0.01 – – 0.0227 0.0156 0.0242 –
O 0.8881 0.1984 0.1794 0.008 0.3196 0.1886 0.3352 0.8014 0.3196
F – – – – – – – – –
Mg – – – – – – 0.0688 – –
Al – – – – – – 0.014 – –
P – – – – – – – 0.0002 –
Cl – 0.0013 0.0096 – – 0.0013 0.0024 0.0002 –
Ca – 0.0232 0.0795 – – 0.0231 – – –
Br – – 0.0003 – – – – – –
Ti – – – 0.012 – – – – –
Density (g cm3) 1 1.03 1.013 1.045 1.19 1.03 1.039 1.026 1.18
Figure 2
Setup of the Geant4 simulation showing: A, vertical slit; B, MSC; C,
phantom (not to scale). The z direction is orthogonally up out of the page.
(Dw). The percentage dose difference






The relative dose distributions were
determined by normalizing the depth
dose profiles to their respective
maximum doses. Likewise, relative
lateral dose profiles were produced by
normalizing to the maximum dose. The
percentage deviation of the relative
dose profiles were derived using equa-
tion (3).
Uncertainty of dose was calculated by
determining the standard error of dose
to 99% confidence in each voxel across
100 simulations of identical fluence, but
unique random seeds. Uncertainty of
D was calculated using standard
propagation of the relative error equa-
tion.
3. Results
3.1. Comparison of the mass energy-
absorption coefficients of the solid
phantoms
Figs. 3 and 4 show the percentage
difference of en= calculated for all
solid phantom materials under study
compared with water, in the energy
range between 1 keV and 300 keV of
interest for MRT. In general, all mate-
rials agree with water within 5% for
energies higher than 150 keV, while substantial differences
can be observed at low energies (below 50 keV). en= of
RMI457 Solid Water and Virtual Water agree within 5–10%
with water between 50 keV and 150 keV, which is the energy
range of the incident MRT photon beam. RW3 also agrees
within 5–10% with water while Plastic Water DT and PAGAT
agree within 5% in the same energy range. Thus, RMI457
Solid Water, Virtual Water, Plastic Water DT, PAGAT and
RW3 are expected to be the most water-equivalent materials.
Nevertheless, the mass energy-absorption coefficient does
not take into account the spatial distribution of the energy
deposition, which plays a crucial role in MRT because of the
limited sizes of the microbeams. This factor is taken into
account in the Geant4 simulation.
3.2. Broad-beam configuration
Dosimetric results were averaged over appropriately
chosen voxels in the centre of the field (CoF) and in a region
outside of the field (OoF) to improve statistics. The chosen
voxel size for this configuration was 2 mm 0.2 mm 0.2 mm
and the regions selected for averaging are shown in Fig. 5. The
dose was integrated over the selected voxels and then divided
by the number of voxels to obtain the average dose in that
region. The average dose was then divided by the number of
simulated primary photons to obtain the average dose per
research papers
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Figure 3
Percentage difference of the mass energy-absorption coefficient ð en=Þ of the solid phantoms
under investigation with respect to water, versus photon energy.
Figure 4
Zoom of Fig. 3 in the photon energy range of interest for MRT (from 50 keV to 150 keV).
Figure 5
YZ (beam’s eye) dose map of the broad-beam configuration showing the
CoF and OoF at 2 cm depth.
incident photon deposited in the phantom. This methodology
is acceptable in regions without steep dose gradients.
Absolute dose distributions, in broad-beam configuration,
for all phantom materials under investigation are shown in
Fig. 6 and summarized in Table 2. Normalized dose distribu-
tions for this configuration are shown in Fig. 7 and summarized
in Table 3.
Simulation results for the broad-beam configuration were
obtained for an incident photon fluence of 6.2  106 mm2 for
each phantom material. The statistical uncertainty of the dose
research papers
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Table 2
Percentage D [as defined in equation (3)] for the phantom materials
under investigation relative to water, in broad-beam configuration for all
depths.
The most water-equivalent materials are highlighted in bold face.
Material CoF OoF
RMI457 Solid Water 1% +5% to 2%
RW3 5% to 6% 7% to 10%
PMMA 8% to <20% 1% to <20%
Plastic Water DT 2% to 4% 1% to 5%
PAGAT 1% to 6% 0% to 5%
Virtual Water 1% +4% to 4%
Perspex 8% to <20% 1% to <20%
Plastic Water +9% to >+20% >+16%
Figure 6
(a) Depth dose profile at the centre of field (CoF). (b) Percentage D in
(a) relative to that in water. (c) Depth dose profiles out of field (OoF).
(d) Percentage D in (c) relative to that in water. (e) Horizontal (y) dose
profile at 2 cm depth. ( f ) Percentage D in (e) relative to that in water.
Percentage D is defined in equation (3).
Table 3
Deviation of the relative dose distribution in phantom materials relative
to water, as defined in equation (3), in broad-beam configuration for all
depths.
The most water-equivalent materials are highlighted in bold face.
Material CoF OoF
RW3 0% to 1% 0% to 3%
PMMA 0% to <20% +1% to <20%
PAGAT 0% to 5% +1% to 6%
Perspex 0% to <20% +1% to <20%
Plastic Water 0% to 17% +8% to <20%
Figure 7
(a) Depth dose curve at the centre of field (CoF). (b) Percentage D in
(a) relative to water. (c) Depth dose curves out of field (OoF).
(d) Percentage D in (c) relative to water. (e) Horizontal (y) dose
profile at 2 cm depth. ( f ) Percentage D in (e) relative to water.
was calculated to be less than 0.8% across all depths at the
CoF and less than 2.4% in the OoF region. In this work,
adequate agreement between phantom material and water is
defined to be within 5% D as in Hugtenburg et al. (2010).
The phantom materials providing best agreement with
water in the CoF are RMI457 Solid Water and Virtual Water
within 1% D and Plastic Water DT within 4% D [see
Figs. 6(a) and 6(b)].
None of the other phantom materials agree with water for
the full depth of the 20 cm  30 cm  30 cm phantom, but it
should be noted that PAGAT fails by only 1% D and RW3
consistently receives doses that are less than water, but that
vary only slightly with depth. These results suggest that RW3,
PAGAT and Plastic Water DT can be used as phantom
materials provided the application of a suitable normalization
factor.
PMMA, Plastic Water and Perspex are clearly unsuitable
for absolute dosimetry in the CoF as they show significant
disagreement.
Virtual Water provides best agreement with water in the
OoF region within 4% D, and RMI457 Solid Water and
Plastic Water DT provide good agreement within 5% D, as
shown in Figs. 6(c) and 6(d). In addition, PAGAT approx-
imates water within 5% D for all depths considered and thus
is a good substitute for water in the OoF region only. It should
be noted that D varies more in the OoF region compared
with in the CoF region for all the solid phantoms [shown better
in Figs. 6(e) and 6( f)].
Figs. 6(e) and 6( f) show the horizontal (y) profile of dose in
the different phantoms at a depth of 2 cm, which corresponds
to a maximum dose in the OoF. While D is relatively
constant across the beam in the CoF at this depth, the devia-
tion of the dose is subject to greater variation in the OoF
region [as noted above in Figs. 6(c) and 6(d)]. This is due to the
dose in the OoF region being orders of magnitude lower than
the dose in the CoF, thus small variations in absolute dose in
the OoF region translate to relatively larger differences from
water than would occur in the CoF.
This can be seen with RMI457 Solid Water, which shows
agreement with water in the broad-beam set-up within 1%
D in the CoF, but in the penumbra the range increases to
+5% to 2% D.
Figs. 7(a) and 7(b) show the relative dose distribution,
normalized to the maximum dose as in Hill et al. (2010), which
has been adopted as a reference to compare our results with.
Note that RMI457 Solid Water, Plastic Water DT and Virtual
Water were not considered for comparison of relative dose as
they had already been shown to agree in the absolute dose
case.
When comparing the relative dose distributions, PAGAT
and RW3 agree within 5% D in the CoF. This agreement was
expected due to the relatively constant 5% D of RW3
across all depths and the fact that PAGAT only exceeded the
agreement threshold by 1% in the absolute case. RW3 in
particular agrees very well within 1% D. Plastic Water,
Perspex and PMMA still do not describe the relative dose
distribution of water with adequate accuracy.
Figs. 7(b) and 7(c) show the normalized depth dose profiles
in the OoF. RW3 agrees very well with water in the OoF
(within 3% D, the best agreement achieved in OoF) but
PAGAT fails to agree in the OoF due to a maximum 6% D.
The remaining materials do not agree with water in either the
CoF or OoF.
3.3. Microbeam configuration
As in the broad-beam case, results were averaged over
appropriately chosen voxels to improve statistics. The voxel
size used here was 1 mm  0.01 mm  0.1 mm, which is
smaller than in the broad-beam case to account for the steeper
dose gradients in the y-direction. The regions chosen for
averaging are shown in Fig. 8. Absolute dose distributions for
the microbeam configuration are shown in Fig. 9 and
summarized in Table 4. Relative dose distributions for this
configuration are shown in Fig. 10 and summarized in Table 5.
Dose was recorded both at the central peak and in the valley
adjacent to the central peak (see Fig. 8).
Simulations with microbeams were obtained with an inci-
dent photon fluence of 3.6  107 mm2 for each phantom
material. Doses delivered were lower and uncertainties higher
despite the larger fluence because the voxel cross-sectional
area in the yz plane is 1/40 of the size of the broad-beam case.
Statistical uncertainty across all depths was calculated to be
less than 2% in the peak and less than 2.3% in the valley.
Given the current lack of dosimetric standards specifically
designed for MRT, in this work adequate agreement with
water was decided to be within 5% D in the peak where
conditions are similar to the broad-beam case. Within the
valley the absolute dose is lower, thus smaller variations in
dose can result in significant deviations when compared with
water. It is therefore reasonable to modify the criteria for
agreement when considering valley regions. The criteria for
good agreement were relaxed slightly to within 6% D. This
is justified by results from Cornelius et al. (2014) and Bräuer-
Krisch et al. (2010) where experimental measurement of dose
in the peak using GafChromic film had relative errors of up to
approximately 15% and 8%, respectively.
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Figure 8
YZ (beam’s eye) dose map of the microbeam configuration showing peak
and valley regions (in black) at 2 cm depth.
Materials that did not agree with water at all in the broad-
beam case (Perspex, Plastic Water and PMMA) were not
considered for the microbeam case in order to reduce simu-
lation times.
The results for the MRT case are shown in Figs. 9(a) and
9(b). In agreement with the results obtained in the broad-
beam configuration, the RMI457 Solid Water and Virtual
Water materials best approximate the absolute dose in a water
phantom in the peak region with a maximum D of 3% and
Plastic Water DT agrees within 5% D.
RW3 and PAGAT do not agree with water in the peak in
terms of absolute dose.
The valley dose profiles are shown in Figs. 9(c) and 9(d). In
this case, the phantom materials show substantial differences
with respect to water in terms of dose. RMI457 Solid Water
and Virtual Water agree within 6% D but span the entire
range of +6% to 5% D. RW3, Plastic Water DT and
PAGAT do not agree within 6% D, though Plastic Water DT
fails by only 1%. RW3 and PAGAT also have a smaller range
of deviation than RMI457 Solid Water and Virtual Water,
which suggests usefulness for relative dose distribution
measurements. Thus, only RMI457 Solid Water and Virtual
Water are considered to be in good agreement with water
(within 6% D) for microbeam dosimetry QA.
The observed dosimetric differences between peak and
valley can be attributed to two facts: firstly that energy
deposited in the valley is due to scattered photons and
secondly that the dose is two orders of magnitude less than in
the peak.
The results indicate that it is difficult to accurately deter-
mine a dose relative to water in any phantom material in the
valleys. The best relative dosimetric agreement between the
considered solid phantoms and water in the OoF is within 6%
D. This fact has to be taken into account when determining
the PVDRs in water from measurements performed in the
investigated solid phantoms, provided that the position of the
peak is known.
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Table 4
Percentage D of phantom materials relative to water, as defined in
equation (3), in microbeam configuration for all depths.
The most water-equivalent materials are highlighted in bold face.
Material Peak Valley
RMI457 Solid Water 0% to 3% +6% to 5%
RW3 3% to 7% 8% to 14%
Plastic Water DT 2% to 5% 1% to 7%
PAGAT 1% to 7% 0% to 8%
Virtual Water 0% to 3% +6% to 5%
Figure 9
(a) Depth dose curve at the peak. (b) Percentage D in (a) relative to
water. (c) Depth dose curve in the valley. (d) Percentage D in (c)
relative to water.
Table 5
Percentage D, calculated from normalized dose of phantom materials
relative to water, as defined in equation (3), in microbeam configuration
for all depths.
The most water-equivalent materials are highlighted in bold face.
Material Peak Valley
RW3 + 2% to 1% +1% to 5%
Plastic Water DT 0% to 3% +1% to 5%
PAGAT 0% to 7% +1% to 7%
Figure 10
(a) Depth dose curve at the peak. (b) Deviation of dose in (a) relative to
that in water. (c) Depth dose curve in the valley. (d) Deviation of dose in
(c) relative to that in water.
The normalized microbeam peak profiles are shown in
Figs. 10(a) and 10(b). Once again, materials that agreed in the
absolute dose case were not considered when calculating
relative dose distributions. As in the broad-beam case, RW3
agrees with water in the peak within 5% D once the dose is
normalized, as does Plastic Water DT, but PAGAT fails to
agree within 5% D. Figs. 10(c) and 10(d) show the same
trend, RW3 and Plastic Water DT agreeing within 6% D and
Plastic Water DT failing by 1%. RW3 and Plastic Water DT
both agree within stated limits and thus both materials are
recommended for use in QA of MRT relative dosimetry.
4. Discussion
Summarizing the results of our simulation study, RMI457
Solid Water, RW3, Plastic Water DT and Virtual Water are
suggested as substitutes for water for MRT QA in the MRT
broad-beam configuration. For the MRT microbeam config-
uration, RMI457 Solid Water and Virtual Water can be used
for absolute dosimetry, while RW3 and Plastic Water DT
can be used for relative dosimetry only. An approximate
normalization factor for the relative dosimetry of microbeams
using RW3 would be 1.05  0.15 for the peak and 1.10  0.15
for the valley regions. In the case of the broad-beam config-
uration, the normalization factor is approximately 1.06  0.05
for the same material.
In the first stage of the study, mass energy-absorption
coefficients en= were calculated for all the solid phantoms in
the photon energy range of interest for MRT. Generally, the
materials that were shown to agree in our simulation study
(PAGAT, Plastic Water DT, RMI457 Solid Water, RW3 and
Virtual Water) also had mass energy-absorption coefficients
that were within a few percent of those of water in the energy
range of interest. It was found that the materials with the
smallest deviation of en= from that of water had better
dosimetric agreement. Likewise, the materials which were
shown to be less water-equivalent from a dosimetric
perspective (PMMA, Perspex and Plastic Water) had en=
values that differed by more than 20% from those of water in
the range of interest.
The energy dependence of en= necessitates knowledge of
the incident energy spectrum in order to select the most
appropriate phantom material. Some manufacturers provide a
recommended range of energies through which their phantom
is most water-equivalent. Plastic Water from CIRS is recom-
mended for the 150 keV to 100 MeV energy ranges, and
Plastic Water DT is recommended from 50 keV to 15 MeV.
Similarly, PTW Freiburg recommends RW3 for photon energy
ranges from 60Co (1.17 and 1.33 MeV) up to 25 MeV. The
results obtained in this work for these particular phantoms
support the recommendation of the manufacturers. However,
this information is not provided by the respective manu-
facturers for the rest of the phantom materials investigated in
this work.
Of particular note is PAGAT, which did not follow the
observed correlation between en= and dosimetric water
equivalence, especially in the microbeam configuration case.
A better dose agreement was expected for PAGAT in the
absolute dose case, given that en= deviated the least from
water. This discrepancy can be explained by the observation
that the vast majority of deposited energy in the phantom
materials is due to Compton scattering, which is dominant
from an energy of 40 keV, and that en= does not take into
account the backscatter or scattering from distant parts of the
radiation field. In larger fields, typical of conventional radio-
therapy, the contribution from scatter is less significant than in
the case of small field sizes of MRT. This is especially true
within the valleys, where the dose is almost entirely due to
scattered photons from distant peaks. Our results indicate that
en= is not sufficient to accurately estimate the water-
equivalence of phantom materials in such small radiation
fields.
Our results agree with Hill et al. (2010) but the exact
magnitude of the relative difference of materials from water
differs. In both studies, RMI457 Solid Water, Virtual Water,
Plastic Water DT, RW3 and PAGAT were all found to be
water-equivalent, whilst Perspex, PMMA and Plastic Water
were not. Disagreements between the exact magnitude of
relative differences of the materials of the two studies (from
2% to 20% depending on the material in question) may be
accounted for by noting that our broad-beam results were
simulated using a smaller field size (1 cm2 field as opposed
to 2 cm2) and smaller voxels (2 mm  0.2 mm  0.2 mm
rectangular prisms as opposed to 10 mm-diameter, 2 mm-thick
cylindrical voxels). Differences also arise due to the fact that
our results were simulated using a different X-ray energy
spectrum (a 300 keV maximum/100 keV mean MRT
X-ray spectrum as opposed to spectra typical of kV treatment,
a 280 keV maximum/93 keV mean).
In our study, the dose was calculated in a phantom to a
depth of 16 cm along the direction of incidence of the beam
as opposed to 6 cm as in Hill et al. (2010). We found that
agreement with water was better for all phantom materials
considered at smaller depths, so some materials that have
failed for the 16 cm depth in our 20 cm phantom may provide
sufficient agreement at shallower depths and/or in smaller
phantoms. With a more relaxed condition for agreement (e.g.
8% D in MRT peak and 10% D in the valley), Plastic
Water DT and PAGAT may be considered for QA dosimetry
even in the absolute dose case, while a stricter condition for
agreement may see no materials deemed suitable. More
complex phantoms such as bone or anatomical phantoms have
yet to be investigated under these conditions and will be the
subject of further testing.
Our simulation study shows that phantom materials that
agreed in the broad-beam case may not be adequate in the
MRT case (specifically PAGAT). Dosimetry within the valley
was found to be more difficult and required averaging in order
to produce acceptable statistics. This is most evident in the
case of RMI457 Solid Water and Virtual Water (when
normalized) where doses agreed within the peak but not in the
valley. Thus, this study shows that the spatial fractionation has
a significant dosimetric effect in phantoms, which cannot be
neglected when performing QA studies for MRT.
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This work demonstrated that the choice of solid phantom
material for QA of MRT must be considered carefully.
Moreover, the chosen phantom must be tested to ensure that
it is truly water-equivalent in synchrotron beam conditions
before use (for example, by comparison of PinPoint ion
chamber readings at equivalent depths in water and solid
phantoms).
5. Conclusion
In this study, the dose deposition from synchrotron X-rays
produced at the ESRF ID17 beamline was simulated in
multiple common phantom materials for broad-beam and
microbeam MRT configurations using Monte Carlo techni-
ques. Alternative phantom materials were compared against
water in terms of dose and the most water-equivalent solid
phantom material was determined under simulated conditions.
Based on the results of this study, the adoption of Virtual
Water, Plastic Water DT, RW3 and RMI457 Solid Water
are recommended for MRT QA as water-equivalent solid
phantom materials. In particular, Virtual Water and RMI457
Solid Water agree with water within 3% relative difference
to water in the peak and 6% in the valley and are recom-
mended for absolute dosimetry. RW3 and Plastic Water DT
agree within3% relative difference to water in the peak and
5% in the valley once normalized and are recommended for
relative dosimetry once normalized. Plastic Water DT can also
be used in broad-beam QA for absolute dosimetry studies.
PMMA, Plastic Water, PAGAT and Perspex are not recom-
mended to be used in relative or absolute dosimetry in MRT.
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Bravin, A., Perevertaylo, V., Rosenfeld, A. B. & Lerch, M. L. F.
(2012). J. Instrum. 7, P07022.
Rosenfeld, A., Siegbah, E. A., Brauer-Krish, E., Holmes-Siedle, A.,
Lerch, M. L. F., Bravin, A., Cornelius, I. M., Takacs, G. J., Painuly,
N., Nettelback, H. & Kron, T. (2005). IEEE Trans. Nucl. Sci. 52,
2562–2569.
Rothkamm, K., Crosbie, J., Daley, F., Bourne, S., Barber, P., Vojnovic,
B., Cann, L. & Rogers, P. (2012). PLoS One, 7, e29853.
Sanchez del Rio, M., Canestrari, N., Jiang, F. & Cerrina, F. (2011).
J. Synchrotron Rad. 18, 708–716.
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